Catalent Pharma Solutions, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price on Dec 17, 2024

Catalent Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2013FY 2012FY 2011FY 2010FY 2009
Period EndingMar '14 Jun '13 Jun '12 Jun '11 Jun '10 Jun '09
Revenue
1,8131,8001,6951,5321,4801,562
Revenue Growth
2.25%6.22%10.64%3.47%-5.20%-14.09%
Gross Profit
582568.6558.6502.1440.9395
Operating Income
236.9228225.5213.8170.8125.2
Net Income
8.2-46.7-40.4-54-289.6-308.1
Earnings Per Share
------
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2013FY 2012FY 2011FY 2010FY 2009
Period EndingMar '14 Jun '13 Jun '12 Jun '11 Jun '10 Jun '09
Cash & Investments
55.7106.4139205.116463.9
Total Debt
2,7012,6922,7072,3892,3252,375
Net Cash (Debt)
-2,646-2,585-2,568-2,184-2,161-2,312
Net Cash Growth
------
Net Cash Per Share
------

Cash Flow & CapEx

Fiscal YearTTMFY 2013FY 2012FY 2011FY 2010FY 2009
Period EndingMar '14 Jun '13 Jun '12 Jun '11 Jun '10 Jun '09
Operating Cash Flow
147.8137.787.999.7233.876.2
Capital Expenditures
-99.7-122.5-104.2-87.3-70.5-78.2
Free Cash Flow
48.115.2-16.312.4163.3-2
Free Cash Flow Growth
----92.41%--

Margins

Fiscal YearTTMFY 2013FY 2012FY 2011FY 2010FY 2009
Period EndingMar '14 Jun '13 Jun '12 Jun '11 Jun '10 Jun '09
Gross Margin
32.10%31.58%32.96%32.78%29.78%25.29%
Operating Margin
13.06%12.67%13.30%13.96%11.54%8.02%
Pretax Margin
2.50%-1.33%1.10%-0.35%-14.55%-15.00%
Profit Margin
0.45%-2.59%-2.38%-3.52%-19.56%-19.73%
FCF Margin
2.65%0.84%-0.96%0.81%11.03%-0.13%